1Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for biopharmaceuticals
3.2.1.2 Increasing outsourcing of sterility testing services
3.2.1.3 Technological advancements in sterility testing
3.2.2 Industry pitfalls & challenges
3.2.2.1 Time-consuming testing process
3.2.2.2 Complex regulatory framework
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Million)
5.1 Key trends
5.2 Kits & reagents
5.3 Services
5.4 Instruments
Chapter 6 Market Estimates and Forecast, By Test, 2021 – 2032 ($ Million)
6.1 Key trends
6.2 Membrane filtration
6.3 Direct inoculation
6.4 Rapid microbial method
6.4.1 ATP bioluminescence
6.4.2 Fluorescent -based
6.4.3 Solid-phase cytometry
6.4.4 Other rapid microbial methods
6.5 Other tests
Chapter 7 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Million)
7.1 Key trends
7.2 In-house
7.3 Outsourced
Chapter 8 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Million)
8.1 Key trends
8.2 Pharmaceutical and biological manufacturing
8.3 Medical devices manufacturing
8.4 Other applications
Chapter 9 Market Estimates and Forecast, By End-User, 2021 – 2032 ($ Million)
9.1 Key trends
9.2 Pharmaceutical & biotechnology companies
9.3 Medical device companies
9.4 CROs and contract testing laboratories
9.5 Other end-users
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 bioMerieux SA
11.2 Charles River Laboratories International Inc.
11.3 Merck KGaA
11.4 Nelson Laboratories, LLC
11.5 Pacific Biolabs
11.6 Rapid Micro Biosystems Inc.
11.7 Sartorius AG
11.8 SGS SA
11.9 Thermo Fisher Scientific Inc.
11.10 WuXi AppTec
